Search Results 1331-1340 of 19021 for Neutrophil

1. Hidradenitis suppurativa - Doctors and departments - Mayo Clinic

   ... Neutrophilic dermatoses. Show more areas of focus for Anagha Bangalore Kumar, M.B.B.S.. Stella X. Chen, M.D.. Dermatologist. Phoenix, AZ ...

2. A Study to Determine Recommended Dose, Regimen and Evaluate the Safety and Preliminary Effectiveness of CC-92480 in Combination With Standard Treatments in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM) - Mayo Clinic

   Participation eligibility · Absolute neutrophil count (ANC) < 1,000/µL (for Phase 1 without growth factor support for ≥ 7 days [≥ 14 days for pegfilgrastim]) ...

3. Study Of Carboplatin And Mirvetuximab Soravtansine In First-Line Treatment Of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube Or Primary Peritoneal Cancer - Mayo Clinic

   * Absolute neutrophil count (ANC) ≥ 1.5 x 109/L (1,500/μL) * Platelet count ≥ 100 x 109/L (100,000/μL) without platelet transfusion in the prior 10 days

4. ROR1771: A Prospective Observational Study of Proton Stereotactic Body Radiation Therapy and Immunotherapy for Recurrent/Progressive Locoregional or Metastatic Head and Neck Cancer - Mayo Clinic

   Neutrophils ≥ 1.5 K/microliter; Platelets ≥ 100 K/microliter; Hemoglobin ≥ 9.0 g/deciliter; Serum Creatinine ≤ 1.5 x ULN or creatinine clearance > 40ml/min ...

5. A Study to Evaluate the Efficacy and Safety of Daratumumab in Combination With Cyclophosphamide, Bortezomib and Dexamethasone (CyBorD) Compared to CyBorD Alone in Newly Diagnosed Systemic Amyloid Light-chain (AL) Amyloidosis - Mayo Clinic

   Absolute neutrophil count ≥1.0 × 109/L;; Hemoglobin level ≥8.0 g/dL (≥5 mmol/L); red blood cell transfusion allowed until 7 days before randomization ...

6. Fecal calprotectin assay performs well as biomarker for measurement of ulcerative colitis disease activity - Mayo Clinic

   Calprotectin is a protein released by activated neutrophils during inflammation. Dr. Loftus and colleagues have reviewed the published literature examining ...

7. The Assessment of Prednisone In Remission Trial - Centers of Excellence Approach - Mayo Clinic

   Positive anti-neutrophil cytoplasmic antibody (ANCA) test specific for proteinase-3 measures by enzyme-linked immunoassay. Patients who are myeloperoxidase ...

8. Study Of Chemotherapy Plus Ipatasertib For People With Solid Tumors With AKT Mutations, A ComboMATCH Treatment Trial - Mayo Clinic

   - Absolute neutrophil count >= 1.5 x 10^3/uL (within 28 days prior to registration) - Platelets >= 100 x 10^3/uL (within 28 days prior to registration)

9. A Study of LOXO-292 in Patients with Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1.0 × 109/L not requiring growth factor support for at least 7 days prior to treatment, and; Platelet count ≥ 75 × 109/L ...

10. A Study to Evaluate Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients with Germ Cell Tumors - Mayo Clinic

    Peripheral absolute neutrophil count (ANC) ≥ 1,000/mm^3. Platelet count ≥ 100,000/mm^3. Patients enrolling on the standard risk arms must be medically fit ...